1-20 of 73
David L. Rimm
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1094: SMARCA4-mediated chromatin remodeling regulates osimertinib resistance in EGFR-mutant lung adenocarcinoma

Fernando J. de Miguel, Wesley L. Cai, Mary Ann Melnick, Camila Robles-Oteiza, Anna Wurtz, Maria I. Toki, David L. Rimm, Robert Homer, Don X. Nguyen, Katerina A. Politi
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1094.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1094
Published: 15 June 2022
View article
Journal Articles

Abstract 1722: Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer (NSCLC)

Miguel Lopez de Rodas Gregorio, Venkata Nagineni, Arvind Ravi, Ila J. Datar, Mari Mino-Kenudson, German Corredor, Cristian Barrera, Lindsey Behlman, David L. Rimm, Roy S. Herbst, Anant Madabhushi, Jonathan W. Riess, Vamsidhar Velcheti, Matthew Hellmann, Justin F. Gainor, Kurt A. Schalper
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1722.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1722
Published: 15 June 2022
View article
Journal Articles

Abstract 1229: miRNA and response to trastuzumab

Giulia Cosentino, Sara Pizzamiglio, Chiara M. Ciniselli, Loris De Cecco, Alessandra Cataldo, Ilaria Plantamura, Tiziana Triulzi, Sarra El-abed, Yingbo Wang, Mohammed Bajji, Paolo Nuciforo, Jens Huober, Susan L. Ellard, David L. Rimm, Andrea Gombos, Mariagrazia Daidone, Paolo Verderio, Elda Tagliabue, Serena Di Cosimo, Marilena V. Iorio
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1229.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1229
Published: 15 June 2022
View article
Journal Articles

Abstract 1242: PD-L1 and PD-L2 mRNA are associated with outcome and high negative predictive value in immunotherapy-treated non-small cell lung cancer

Aileen I. Fernandez, Niki Gavrielatou, Leena McCann, Saba Shafi, Myrto K. Moutafi, Sandra Martinez-Morilla, Ioannis Vathiotis, Thazin Nwe Aung, Vesal Yaghoobi, Yalai Bai, Jodi Weidler, Michael Bates, David L. Rimm
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1242.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1242
Published: 15 June 2022
View article
Journal Articles

Abstract 2027: Spatial omics and multiplexed imaging to discover new biomarkers of response or resistance to immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC)

Myrto Moutafi, Sandra Martinez-Morilla, Rolando Garcia-Milian, Thazin Nwe Aung, Ioannis Vathiotis, Niki Gavrielatou, Vasiliki Xirou, Leonidas Salichos, David L. Rimm
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2027.
DOI: https://doi.org/10.1158/1538-7445.AM2022-2027
Published: 15 June 2022
View article
Journal Articles

Abstract 2028: Spatially resolved proteomic profiling identifies tumor cell CD44 as a novel indicative biomarker of sensitivity to PD-1 axis blockade in advanced non-small cell lung cancer (NSCLC)

Myrto Moutafi, Magdalena Molero, Sandra Martinez-Morilla, Javier Baena, Ioannis Vathiotis, Niki Gavrielatou, Laura Castro, Gorka Ruiz de Garibay, Vera Adradas, Daniel Orive, Karmele Valencia, Alfonso Galvo, Luis M. Montuenga, Santiago Ponce, Kurt Schalper, Luis Paz-Ares, David L. Rimm, Jon Zugazagoitia
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2028.
DOI: https://doi.org/10.1158/1538-7445.AM2022-2028
Published: 15 June 2022
View article
Journal Articles

Abstract P1-02-02: Examination of low Her2 expression in breast cancer

Aileen I Fernandez, Matthew Liu, Andrew Bellizzi, Jane Brock, Oluwole Fadare, Krisztina Hanley, Malini Harigopal, Julie M. Jorns, M. Gabriela Kuba, Amy Ly, Mirna Podoll, Kimmie Rabe, Mary Ann Sanders, Kamaljeet Singh, Olivia L Snir, Rinda Soong, Shi Wei, Hannah Wen, Serena Wong, Esther Yoon, Lajos Pusztai, Emily Reisenbichler, David L. Rimm
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-02-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-02-02
Published: 15 February 2022
View article
Journal Articles

Abstract P4-03-01: Budding Tumorigenesis: A novel proposed model for breast cancer tumorigenesis

Vesal Yaghoobi, Thazin NWE Aung, Myrto Moutafi, Tyler L Cooke, David L Rimm
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P4-03-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P4-03-01
Published: 15 February 2022
View article
Journal Articles

Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes

Maria Apostolidi, Ioannis A. Vathiotis, Viswanathan Muthusamy, Patricia Gaule, Brandon M. Gassaway, David L. Rimm, Jesse Rinehart
Journal: Cancer Research
Cancer Res (2021) 81 (16): 4346–4359.
DOI: https://doi.org/10.1158/0008-5472.CAN-20-4190
Published: 15 August 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 339: Resistance to trastuzumab is associated with alpha-smooth muscle actin expression in the stroma of patients with HER2+ breast cancer

Ioannis A. Vathiotis, Myrto K. Moutafi, Prajan Divakar, Thazin Nwe Aung, Aileen Fernandez, Vesal Yaghoobi, Saba Shafi, Konstantinos N. Syrigos, George Fountzilas, Lajos Pusztai, Sarah Warren, David L. Rimm
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 339.
DOI: https://doi.org/10.1158/1538-7445.AM2021-339
Published: 01 July 2021
View article
Journal Articles

Abstract 3095: Combination of spatial protein data with bulk transcriptional profiling of the same cohort shows relationships between RNA and protein and facilitates combined predictive signatures

Ioannis A. Vathiotis, Jason Reeves, Maria Toki, Pok Fai Wong, Harriet Kluger, Thazin Nwe Aung, Konstantinos N. Syrigos, Sarah Warren, David L. Rimm
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3095.
DOI: https://doi.org/10.1158/1538-7445.AM2020-3095
Published: 15 August 2020
View article
Journal Articles

Abstract 2002: Assessment of the co-localization between PD-L1 positive macrophages and PD-1 positive cells is associated with benefit from PD-1 axis immunotherapy in NSCLC

Yuting Liu, Jon Zugazagoitia, Kurt A. Schalper, Roy S. Herbst, David L. Rimm
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 2002.
DOI: https://doi.org/10.1158/1538-7445.AM2020-2002
Published: 15 August 2020
View article
Journal Articles

Abstract 2001: Biomarker discovery in immunotherapy-treated melanoma patients with imaging mass cytometry

Sandra Martinez-Morilla, Franz Villarroel-Espindola, Pok Fai Wong, Harriet Kluger, Maria Toki, Thazin New Aung, Vasiliki Pelekanou, Brian Bourke-Martin, David L. Rimm
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 2001.
DOI: https://doi.org/10.1158/1538-7445.AM2020-2001
Published: 15 August 2020
View article
Journal Articles

Abstract 1998: Predictive and prognostic role of T- and B-cell receptor repertoire in HER2-positive breast cancer: An analysis of the NeoALTTO clinical trial

Mattia Rediti, David Venet, Françoise Rothé, Tao Qing, Marion Maetens, Ian Bradbury, Miguel A. Izquierdo, Serena Di Cosimo, Florentine Hilbers, Mohammed Bajji, Nadia Harbeck, Michael Untch, David L. Rimm, Stephen Chia, Minetta C. Liu, Cristina Saura, Jens Huober, Paolo Nuciforo, Roberto Salgado, Sherene Loi, Lajos Pusztai, Christos Sotiriou
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1998.
DOI: https://doi.org/10.1158/1538-7445.AM2020-1998
Published: 15 August 2020
View article
Journal Articles

Abstract 937: Quantitative assessment of CD200 and CD200R expression in lung cancer

Ioannis A. Vathiotis, Tyler MacNeil, Jon Zugazagoitia, Sandra Martinez-Morilla, Fahad Ahmed, Konstantinos N. Syrigos, Aaron M. Gruver, Kyla Driscoll, David L. Rimm
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 937.
DOI: https://doi.org/10.1158/1538-7445.AM2020-937
Published: 15 August 2020
View article
Journal Articles

Abstract 5525: VISTA/PSGL1 axis as a dominant immunomodulatory pathway in human non-small cell lung cancer

Alicia Ding, Franz Villarroel-Espindola, Adam Ducler, Brian S. Henick, Shruti Desai, Nicole Gianino, Jon Zugazagoitia, David L. Rimm, Alain Robert, Francisco Cruzalegui, Pierre Ferré, Roy Herbst, Miguel Sanmamed, Lieping Chen, Kurt A. Schalper
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 5525.
DOI: https://doi.org/10.1158/1538-7445.AM2020-5525
Published: 15 August 2020
View article
Journal Articles

Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study

Balazs Acs, Samuel C.Y. Leung, Kelley M. Kidwell, Indu Arun, Renaldas Augulis, Sunil S. Badve, Yalai Bai, Anita L. Bane, John M.S. Bartlett, Jane Bayani, Gilbert Bigras, Annika Blank, Signe Borgquist, Henk Buikema, Martin C. Chang, Robin L. Dietz, Andrew Dodson, Anna Ehinger, Susan Fineberg, Cornelia M. Focke, Dongxia Gao, Allen M. Gown, Carolina Gutierrez, Johan Hartman, Judith C. Hugh, Zuzana Kos, Anne-Vibeke Lænkholm, Arvydas Laurinavicius, Richard M. Levenson, Rustin Mahboubi-Ardakani, Mauro G. Mastropasqua, Takuya Moriya, Sharon Nofech-Mozes, C. Kent Osborne, Liron Pantanowitz, Frédérique M. Penault-Llorca, Tammy Piper, Mary Anne Quintayo, Tilman T. Rau, Stefan Reinhard, Stephanie Robertson, Takashi Sakatani, Roberto Salgado, Melanie Spears, Jane Starczynski, Tomoharu Sugie, Bert van der Vegt, Giuseppe Viale, Shakeel Virk, Lila A. Zabaglo, Daniel F. Hayes, Mitch Dowsett, Torsten O. Nielsen, David L. Rimm, International Ki67 in Breast Cancer Working Group, BIG-NABCG
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-02-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P5-02-01
Published: 15 February 2020
View article
Journal Articles

Abstract PD5-01: Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays in triple negative breast cancer

Emily Suzanne Reisenbichler, Gang Han, Vasiliki Pelekanou, Vesal Yaghoobi, Fahad S Ahmed, Andrew Bellizzi, Veerle Bossuyt, Jane Brock, Kimberly Cole, Oluwole Fadare, Omar Hameed, Krisztina Hanley, Beth T Harrison, M G Kuba, Amy Ly, Dylan Miller, Mirna Podoll, Anja C Roden, Mary A Sanders, Kamaljeet Singh, Shi Wei, Hannah Wen, Lajos Pusztai, David L Rimm
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD5-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-PD5-01
Published: 15 February 2020
View article
Journal Articles

Abstract P3-08-12: An open source, automated tumor infiltrating lymphocyte algorithm for prognosis in triple-negative breast cancer

Yalai Bai, Balazs Acs, Jon Zugazagoitia, Sandra Martinez-Morilla, Fahad Shabbir Ahmed, David L. Rimm
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P3-08-12.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P3-08-12
Published: 15 February 2020
View article
Journal Articles

Abstract P4-10-14: Quantitative assessment of PD-L1 protein expression on macrophages and tumor cells as predictive markers of response to neoadjuvant durvalumab and chemotherapy in triple negative breast cancer (TNBC)

Fahad Shabbir Ahmed, John McGuire, Patricia Gaule, Kim Blenman, Lajos Pusztai, David L Rimm
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P4-10-14.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P4-10-14
Published: 15 February 2020
View article